Detalles de la búsqueda
1.
Stereotactic ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocol.
Cancer
; 129(18): 2798-2807, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37221679
2.
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Lancet
; 399(10338): 1886-1901, 2022 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35569466
3.
Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative Data.
Oncologist
; 27(8): 675-684, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35552444
4.
Radiation Oncologist Consultations Prior to Radical Prostatectomy: Disparities and Opportunities.
J Urol
; 207(1): 118-126, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34445893
5.
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions.
J Urol
; 208(1): 26-33, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35536141
6.
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management.
J Urol
; 208(1): 10-18, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35536144
7.
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up.
J Urol
; 208(1): 19-25, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35536148
8.
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial.
BMC Cancer
; 22(1): 746, 2022 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35804307
9.
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.
Lancet
; 393(10185): 2051-2058, 2019 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30982687
10.
Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial.
BMC Cancer
; 20(1): 978, 2020 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33036579
11.
Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial.
BMC Cancer
; 19(1): 1206, 2019 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31829203
12.
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
BMC Cancer
; 19(1): 816, 2019 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31426760
13.
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.
J Urol
; 199(3): 683-690, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29203269
14.
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options.
J Urol
; 199(4): 990-997, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29331546
15.
Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases.
J Neurooncol
; 128(3): 431-6, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27084705
16.
Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.
Cancer
; 121(14): 2422-30, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25847819
17.
Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
Acta Oncol
; 54(10): 1781-7, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25825957
18.
Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapy.
Acta Oncol
; 54(3): 322-32, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25350526
19.
Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada.
Oncologist
; 19(8): 880-5, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24951606
20.
Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial.
BMC Cancer
; 14: 934, 2014 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25496482